跳至主要内容
临床试验/NCT04056637
NCT04056637终止不适用

Choice of Modality of Follow up for Medication Abortion

Stanford University2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2019年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
26
试验地点
2
主要终点
Percent follow-up after medication abortion by group

研究概览

简要总结

This study will assess the impact of providing medication abortion-seeking clients a choice for follow-up in practice. Clients presenting at or less than 63 days pregnant (based on last menstrual period) at the study site for first trimester medication abortion will be invited to participate. We hypothesize that providing clients with flexible follow-up options will improve follow-up rates.

This study is not to assess efficacy or safety of follow-up methods--that has been well established in practice and research. This is to assess choice of follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Eligible for medication abortion <63 days gestational age
  • In general good health
  • English or Spanish speaking competency
  • Willing and able to sign consent forms

排除标准

  • Clients less than 18 years of age.
  • Any client not meeting the inclusion criteria listed above will be excluded from participating in the trial.

结局指标

主要结局

Percent follow-up after medication abortion by group

时间窗: 5-14 days following mifepristone administration

To compare rates of follow-up among clients who are instructed to come back to the clinic for in-person ultrasound medication abortion follow-up to clients who are given options for follow-up, including in-person ultrasound, repeat serum beta-hCG and MLPT

次要结局

  • Percent follow-up after medication abortion by follow-up type(5-14 days following mifepristone administration)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验